Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-09-21
2000-09-26
Ford, John M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5142325, 5142322, 5142338, 5142342, 5142345, 5142358, 51425214, 5142278, 5142282, 5142285, 51425216, 51425217, 514256, 514257, 514258, 514259, 514261, 514266, 544315, 544264, 544278, 544316, 544296, 544255, 544317, 544256, 544262, 544318, 544295, 544121, 544253, 544122, 544115, 544116, 544123, 544 80, 544117, 544 586, 544 81, 544118, 544 90, 544 61, C07D23934, C07D40312, A61K 31505
Patent
active
06124306&
ABSTRACT:
The subject invention relates to pyrimidine-thioalkyl and alkylether compounds of Formula I ##STR1## and pyrimidine-thioalkyl and alkylethers of Formula I, where R.sub.4 is selected from the group consisting of --H or --NR.sub.15 R.sub.16 where R.sub.15 is --H and R.sub.16 is --H, C.sub.1 -C.sub.6 alkyl, --NH.sub.2 or R.sub.15 and R.sub.16 taken together with the --N form 1-pyrrolidino, 1-morpholino or 1-piperidino; and
REFERENCES:
patent: 4724232 (1988-02-01), Rideout et al.
patent: 5025016 (1991-06-01), Ahrens et al.
Schickaneder, H. et al., 2-[3-Pyridinylmethyl)thio]pyrimidine Derivatives: New Bronchosecretolytic Agents, J. Med. Chem., 30:547-551 (1987).
Baker, B.R. et al., Puromycin. Synthetic Studies. VI. Analogs of 6-Dimethylaminopurine, J. Org. Chem., 19:1793-1801 (1954).
Science, 234:661-662 (1986).
Curran, J.W. et al., The Epidemiology of AIDS: Current Status and Future Prospects, Science, 229:1352-1357 (1985).
Pauwels, R. et al., Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives, Nature, 343:470-474 (1990).
Koppel, H.C., et al., Pyrimidines. V. Analogs of 2-(o-Chlorobenzylthio)-4-dimethylamino-5-methylpyrimidine, J. Org. Chem., 27:181-185 (1962).
Ward, A.D. and B.R. Baker, Irreversible Enzyme Inhibitors. 200. Active-Site-Directed Inhibitors of Deoxycytidine Kinase, J. Med. Chem., 20:88-92 (1977).
Budesinsky, Z. et al., 5-(3-Iodopropargyloxy)Pyrimidines as Effective Fungistatics, Collect. Czech. Chem. Comm., 40:1078-1088 (1975);--CA 83:114326e.
Koppel, H.C., et al., Pyrimidines. IV. Aziridinylpyrimidines, J. Org. Chem., 26:1884-1890 (1961).
Tjarks, W. and D. Gabel, Boron-Containing Thiouracil Derivatives for Neutron-Capture Therapy of Melanoma, J. Med. Chem. 34:315-319 (1991).
Kropf, H. et al., 4-t-Butylperoxypyrimidine, 2-4-Di-t-butylperoxy- und 4,6-Di-t-butylperoxypyrimidine, Synthesis, 397-400 (1981).
Vainilavicius, P. et al., Hydrazones based on 5-ethyl-6-methyl-2-thiouracil, Chemical Abstracts, vol. 80 (21) Abstract No. 120861e [1974].
Hashizume, K. and S. Inoue, Model experiments on surugatoxin synthesis. III. Synthesis of 2,4-dibenzyloxy-6-ethylsulfonyl-5-nitropyrimidine, Chemical Abstracts vol. 104 (3), Abstract No. 19434g [1986].
Chebib, M. and R.J. Quinn, 1-Phenylpyrazolo[3,4-d]pyrimidines as Adenosine Antagonists: the Effects of Substituents at C4 and C6, Bioorganic & Medicinal Chemistry, 5(2):311-322 (1997).
Althaus, I.W., et al., The Benzylthio-Pyrimidine U-31,355, a Potent Inhibitor of HIV-1 Reverse Transcriptase, Biochemical Pharmacology, 51:743-750 (1996).
Merluzzi, V.J. et al., Inhibition of HIV-1 Replication by a Nonnucleoside Reverse Trancriptase Inhibitor, Science, 250:1411 (1990).
Adams Wade J.
Friis Janice M.
Morris Joel
Wishka Donn G.
Ford John M.
Pharmacia & Upjohn Company
Solomon Andrew M.
LandOfFree
Thioalkyl alpha substituted pyrimidine compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thioalkyl alpha substituted pyrimidine compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thioalkyl alpha substituted pyrimidine compounds will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100484